Mojca Stegnar

1.6k citations
76 papers · 1.4k · h-index 21

Impact in

    • Venous Thromboembolism Diagnosis and Management
  • Hematology top 2%
    • Blood Coagulation and Thrombosis Mechanisms
    • Platelet Disorders and Treatments

Papers in

    • Blood Coagulation and Thrombosis Mechanisms 50
    • Platelet Disorders and Treatments 5
    • Venous Thromboembolism Diagnosis and Management 6

Mojca Stegnar

74 papers receiving 1.3k citations

Peers

Mojca Stegnar
Comparison fields: 5 of 81
  • Internal Medicine 139
  • Hematology 462
  • Pharmacology 222
  • Cardiology and Cardiovascular Medicine 114
  • Rheumatology 65
Replace Peter Paul Nawroth with:
Peter Paul Nawroth Germany
Vijay V. Upreti United States
Rémi Varin France
Satoshi Kunitada United States
Linda M. Hiebert Canada
Daniel James Crona United States
Margareta Elg Sweden
Yuichi Nakamura Japan
Daniel D. Gretler United States
Stelio Kapiotis Austria
Mojca Stegnar relative to Peter Paul Nawroth Germany Peter Paul Nawroth's profile →
Citations per field
00.5×2×4×6×8.7×
Peter Paul Nawroth · 1×
Citations per year

Countries citing papers authored by Mojca Stegnar

Since Specialization
Citations

This map shows the geographic impact of Mojca Stegnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Stegnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Stegnar more than expected).

Fields of papers citing papers by Mojca Stegnar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojca Stegnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Stegnar. The network helps show where Mojca Stegnar may publish in the future.

Co-authors

The 25 scholars most cited alongside Mojca Stegnar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mojca Stegnar Line = papers co-authored together Mojca Stegnar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2005108
2 2006101
3 199993
4 199677
5 200863
6 200550
7 200249
8 199345
9 200641
10 200439
11 200434
12 200130
13 199129
14 200329
15 199026
16 200625
17 197923
18 200223
19 200922
20 197921

About Mojca Stegnar

Mojca Stegnar is a scholar working on Hematology, Internal Medicine, Pulmonary and Respiratory Medicine, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 76 papers that have together received 1.4k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (50 papers), Blood properties and coagulation (9 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Synthesis and biological activity (6 papers), Platelet Disorders and Treatments (5 papers), Peripheral Artery Disease Management (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Internal Medicine (139 citations), Hematology (462 citations), Pharmacology (222 citations), Cardiology and Cardiovascular Medicine (114 citations) and Rheumatology (65 citations). Mojca Stegnar has collaborated with scholars based in Slovenia, Austria and Netherlands. Frequent co-authors include Polona Peternel, Mojca Božič Mijovski, Dusan Keber, Katja Breskvar, Vita Dolzan, Alenka Mavri, D. Kikelj, Aleš Blinc, Nina Vene and Janez Ilaš. Their work appears in journals such as Thrombosis Research, Thrombosis and Haemostasis, Clinical Chemistry and Laboratory Medicine (CCLM), Bioorganic & Medicinal Chemistry Letters and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact